DrugPatentWatch Database Preview

Ironshore Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for IRONSHORE PHARMS, and what generic alternatives to IRONSHORE PHARMS drugs are available?

IRONSHORE PHARMS has one approved drug.

There are eight US patents protecting IRONSHORE PHARMS drugs.

There are twenty-two patent family members on IRONSHORE PHARMS drugs in fourteen countries.

Summary for Ironshore Pharms

International Patents:	22
US Patents:	8
Tradenames:	1
Ingredients:	1
NDAs:	1

Drugs and US Patents for Ironshore Pharms

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ironshore Pharms	JORNAY PM	methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	209311-005	Aug 8, 2018		RX	Yes	No	9,023,389		Y
Ironshore Pharms	JORNAY PM	methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	209311-004	Aug 8, 2018		RX	Yes	No	9,283,214		Y
Ironshore Pharms	JORNAY PM	methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	209311-002	Aug 8, 2018		RX	Yes	No	8,927,010		Y
Ironshore Pharms	JORNAY PM	methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	209311-001	Aug 8, 2018		RX	Yes	No

International Patents for Ironshore Pharms Drugs

Country	Patent Number	Estimated Expiration
South Africa	201307649
Denmark	2688557
China	103608004
South Korea	101834033

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Ironshore Pharms
• Ironwood Pharms Inc